SG Americas Securities LLC Reduces Stock Holdings in Stericycle, Inc. (NASDAQ:SRCL)

SG Americas Securities LLC lessened its position in Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 78.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,944 shares of the business services provider's stock after selling 22,144 shares during the period. SG Americas Securities LLC's holdings in Stericycle were worth $295,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Ancora Advisors LLC bought a new stake in Stericycle in the 1st quarter valued at $34,000. Quarry LP acquired a new position in shares of Stericycle in the first quarter valued at $30,000. First Capital Advisors Group LLC. bought a new position in shares of Stericycle in the second quarter valued at about $36,000. International Assets Investment Management LLC acquired a new stake in shares of Stericycle during the 3rd quarter worth about $36,000. Finally, Point72 Middle East FZE bought a new stake in shares of Stericycle during the 4th quarter worth about $39,000. 98.82% of the stock is currently owned by institutional investors and hedge funds.

Stericycle Price Performance

Shares of SRCL traded down $1.38 during trading hours on Wednesday, hitting $50.14. 354,603 shares of the company were exchanged, compared to its average volume of 456,697. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.51. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The company has a market cap of $4.65 billion, a price-to-earnings ratio of -214.66, a P/E/G ratio of 2.80 and a beta of 1.09. The firm's fifty day moving average is $51.24 and its 200 day moving average is $47.75.

Stericycle (NASDAQ:SRCL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 28th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.47 by $0.07. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The firm had revenue of $652.00 million for the quarter, compared to the consensus estimate of $657.99 million. During the same period in the prior year, the company posted $0.60 earnings per share. The business's revenue for the quarter was down 2.7% on a year-over-year basis. On average, equities analysts anticipate that Stericycle, Inc. will post 2.31 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Royal Bank of Canada reissued an "outperform" rating and issued a $69.00 price target on shares of Stericycle in a report on Thursday, March 7th. Wells Fargo & Company boosted their price target on Stericycle from $40.00 to $48.00 and gave the company an "underweight" rating in a research note on Friday, March 1st. Truist Financial increased their price objective on Stericycle from $50.00 to $57.00 and gave the stock a "hold" rating in a research report on Thursday, February 29th. StockNews.com cut shares of Stericycle from a "buy" rating to a "hold" rating in a research report on Tuesday, April 2nd. Finally, Stifel Nicolaus raised their price target on shares of Stericycle from $70.00 to $75.00 and gave the stock a "buy" rating in a research report on Thursday, February 29th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $62.25.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.